Insider Sale by Bernstein Harold (President, R&D & CMO)
Trade Summary
2 days ago, Bernstein Harold, serving as President, R&D & CMO at Maze Therapeutics, Inc. (MAZE), sold 16,141 shares at $26.36 per share, for a total transaction value of $425,512.27.
This sale represents a 100.00% decrease in Bernstein Harold's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, September 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, September 3, 2026 at 4:24 PM ET, 2 days after the trade was made.
Maze Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$26.36
Quantity
16,141
Total Value
$425,512.27
Shares Owned
0
Trade Date
2 days ago
SEC Filing Date
at 4:24 PM ET
Filed 2 days after trade
Discussion